Literature DB >> 10712523

The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.

M Le Gall1, J C Chambard, J P Breittmayer, D Grall, J Pouysségur, E Van Obberghen-Schilling.   

Abstract

Anchorage removal like growth factor removal induces apoptosis. In the present study we have characterized signaling pathways that can prevent this cell death using a highly growth factor- and anchorage-dependent line of lung fibroblasts (CCL39). After anchorage removal from exponentially growing cells, annexin V-FITC labeling can be detected after 8 h. Apoptosis was confirmed by analysis of sub-G1 DNA content and Western blotting of the caspase substrate poly (ADP-ribose) polymerase. Growth factor withdrawal accelerates and potentiates suspension-induced cell death. Activation of Raf-1 kinase in suspension cultures of CCL39 or Madin-Darby canine kidney cells stably expressing an estrogen-inducible activated-Raf-1 construct (DeltaRaf-1:ER) suppresses apoptosis induced by growth factor and/or anchorage removal. This protective effect appears to be mediated by the Raf, mitogen- or extracellular signal-regulated kinase kinase (MEK), and mitogen-activated protein kinase module because it is sensitive to pharmacological inhibition of MEK-1 and it can be mimicked by expression of constitutively active MEK-1 in CCL39 cells. Finally, apoptosis induced by disruption of the actin cytoskeleton with the Rho-directed toxin B (Clostridium difficile) is prevented by activation of the DeltaRaf-1:ER chimeric construct. These findings highlight the ability of p42/p44 mitogen-activated protein kinase to generate survival signals that counteract cell death induced by loss of matrix contact, cytoskeletal integrity, and extracellular mitogenic factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712523      PMCID: PMC14834          DOI: 10.1091/mbc.11.3.1103

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  45 in total

Review 1.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

2.  Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.

Authors:  C von Eichel-Streiber; U Harperath; D Bosse; U Hadding
Journal:  Microb Pathog       Date:  1987-05       Impact factor: 3.738

Review 3.  Anchorage dependence, integrins, and apoptosis.

Authors:  E Ruoslahti; J C Reed
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

4.  Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner.

Authors:  Y Fujio; K Walsh
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

5.  Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling.

Authors:  T H Holmström; S C Chow; I Elo; E T Coffey; S Orrenius; L Sistonen; J E Eriksson
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

6.  Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells.

Authors:  T Kinoshita; M Shirouzu; A Kamiya; K Hashimoto; S Yokoyama; A Miyajima
Journal:  Oncogene       Date:  1997-08-07       Impact factor: 9.867

7.  Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells.

Authors:  Y Ishizaki; L Cheng; A W Mudge; M C Raff
Journal:  Mol Biol Cell       Date:  1995-11       Impact factor: 4.138

8.  Insulin-like growth factor-I-mediated survival from anoikis: role of cell aggregation and focal adhesion kinase.

Authors:  B Valentinis; K Reiss; R Baserga
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

9.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

10.  Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression.

Authors:  J H Yeh; S C Hsu; S H Han; M Z Lai
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  37 in total

1.  Analysis of the transcriptional program induced by Raf in epithelial cells.

Authors:  A Schulze; K Lehmann; H B Jefferies; M McMahon; J Downward
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

2.  Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway.

Authors:  M Jost; T M Huggett; C Kari; U Rodeck
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

3.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

Review 4.  The role of the cell-matrix interface in aging and its interaction with the renin-angiotensin system in the aged vasculature.

Authors:  Maria De Luca
Journal:  Mech Ageing Dev       Date:  2018-04-04       Impact factor: 5.432

5.  Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1.

Authors:  Kerrington D Smith; James J Mezhir; Kai Bickenbach; Jula Veerapong; Jean Charron; Mitchell C Posner; Bernard Roizman; Ralph R Weichselbaum
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Mechanical compression of articular cartilage induces chondrocyte proliferation and inhibits proteoglycan synthesis by activation of the ERK pathway: implications for tissue engineering and regenerative medicine.

Authors:  James A Ryan; Eric A Eisner; Grayson DuRaine; Zongbing You; A Hari Reddi
Journal:  J Tissue Eng Regen Med       Date:  2009-02       Impact factor: 3.963

Review 7.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

8.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 9.  From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

Authors:  Christophe Frémin; Sylvain Meloche
Journal:  J Hematol Oncol       Date:  2010-02-11       Impact factor: 17.388

10.  Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation.

Authors:  Yao Yao; Wei Li; Junwei Wu; Ursula A Germann; Michael S S Su; Keisuke Kuida; Diane M Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.